Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels.

Organisation Organisation UCB S.A. (Euronext: UCB)
  Group UCB (Group)
Products Product Briviact®
  Product 2 Vimpat®
Persons Person Tellier, Jean-Christophe (201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis)
  Person 2 Witte, Antje (UCB 201601 Investor Relations)
     


   
Record changed: 2017-10-30

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px

More documents for UCB (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top